EyePoint Pharmaceuticals

$0.526
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0117 (+2.27%) As of 1:04 PM EST today

Why Robinhood?

You can buy or sell EYPT and other stocks, options, and ETFs commission-free!

About EYPT

EyePoint Pharmaceuticals, Inc. Common Stock, also called EyePoint Pharmaceuticals, is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA. The listed name for EYPT is EyePoint Pharmaceuticals, Inc. Common Stock.

CEO

Nancy Sue Lurker

Employees

Headquarters

Watertown, Massachusetts

Founded

1987

Market Cap

75.26M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.37M

High Today

$0.5298

Low Today

$0.51

Open Price

$0.51

Volume

388.19K

52 Week High

$2.10

52 Week Low

$0.3511

Collections

EYPT Earnings

-$0.20

-$0.13

-$0.07

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Mar 4, Pre-Market